Perfluorooctyl bromide

Warning

H315 (90.9%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (90.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H335 (89.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

H413: May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]

Skin Irrit. 2 (90.9%)；Eye Irrit. 2 (90.9%)；STOT SE 3 (89.1%)

Hazardous to the aquatic environment (Long-term) - Category 4

V - Various；V08 - Contrast media；V08C - Magnetic resonance imaging contrast media；V08CX - Other magnetic resonance imaging contrast media；V08CX01 - Perflubron

QV - Various；QV08 - Contrast media；QV08C - Magnetic resonance imaging contrast media；QV08CX - Other magnetic resonance imaging contrast media；QV08CX01 - Perflubron

Perflubron emulsion (Oxygent) maintains hemodynamic stability during major surgery, thereby potentially reducing or avoiding intraoperative transfusions of donor blood in major surgery.Perflubron emulsion has ability to enable patients to be physiologically stable and safe at lower intraoperative Hb levels.

Substances used to allow enhanced visualization of tissues.

Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.

Agents that increase energy expenditure and weight loss by neural and metabolic regulation.

• Ophthalmology [Ref: https://doi.org/10.1155/2014/250323]；• Oxygen carrier for artificial blood [Ref: https://doi.org/10.1039/c7gc03081a]；• Solvent for printing ink [Ref: CAS2019 (CN109810567)]；• X-ray imaging [Ref: https://doi.org/10.1007/978-1-4899-1202-2]；• Supply of gases, including CO2, to microbial cells [Ref: https://doi.org/10.1007/978-1-4899-1202-2]

non-polymer PFAS -> Printing (Inks) -> Toner and printer inks；non-polymer PFAS -> Pharmaceutical Industry -> Processing aid in the manufacture of “microporous” particles；non-polymer PFAS -> Medicinal Utensils -> Retinal detachment surgery and proliferative vitreoretinopathy；non-polymer PFAS -> Medicinal Utensils -> Supplement conventional blood transfusion and artificial blood and perfusion of isolated organs；non-polymer PFAS -> Medicinal Utensils -> Contrast agent；non-polymer PFAS -> Biotechnology -> Supply of oxygen and other gases to cells in culture